Related Experiment Video
Updated: Jan 13, 2026

06:19
Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches
Published on: June 16, 2023
3.8K
Electrostatic Targeting of Cancer Cell Membrane Models by NA-CATH:ATRA-1-ATRA-1: A Biophysical Perspective
Maria C Klaiss-Luna1, Małgorzata Jemioła-Rzemińska2, Marcela Manrique-Moreno1
1Chemistry Institute, Faculty of Exact and Natural Sciences, University of Antioquia A.A 1226, Medellin 050010, Colombia.
Membranes
|October 28, 2025
Summary
This study explored a synthetic peptide, NA-CATH:ATRA-1-ATRA-1, for breast cancer therapy. The peptide shows promise by targeting cancer cell membranes through electrostatic attraction to specific lipids.
Area of Science:
- Biophysics
- Molecular Biology
- Cancer Research
Background:
- Breast cancer is a leading global diagnosis in women.
- Novel therapeutic compounds are urgently needed.
- Cationic peptides show potential due to their membrane-targeting mechanisms.
Purpose of the Study:
- To conduct an initial biophysical assessment of the synthetic peptide NA-CATH:ATRA-1-ATRA-1.
- To investigate the peptide's interactions with lipid bilayers mimicking cancerous and healthy cell membranes.
Main Methods:
- Differential scanning calorimetry (DSC).
- Fourier-transform infrared spectroscopy (FTIR).
- Lipid bilayer interaction studies.
Main Results:
- NA-CATH:ATRA-1-ATRA-1 demonstrated a strong affinity for eukaryotic membrane lipids.
- The peptide showed particular affinity for phosphatidylserine.
- Evidence suggests electrostatic attraction to negatively charged lipids on cancer cell membranes.
Conclusions:
- The findings provide crucial biophysical insights into the peptide's mechanism of action.
- NA-CATH:ATRA-1-ATRA-1's interaction with cancer cell membranes warrants further investigation for therapeutic potential.
- This research supports the development of membrane-active peptides for future cancer therapies.
Related Concept Videos
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Chemotaxis and Direction of Cell Migration
4.4K
Cells can detect chemical cues in their environment and reorganize the cytoskeleton to migrate toward them or away from them. This directional migration, called chemotaxis, is essential during embryogenesis and development, immune response, tissue repair and regeneration, and reproduction. These chemical cues can either attract or repel the cell's movement. For example, axon development is determined by a combination of chemoattractants and chemorepellents that direct the growing axon...
4.4K

